M
MoonLake Immunotherapeutics
NASDAQ:MLTX
MoonLake Immunotherapeutics
NASDAQ:MLTX
Price:
17.36
USD
5.08%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
CH |
|
J
|
John Cockerill India Ltd
BSE:500147
|
IN |
|
Brookside Energy Ltd
ASX:BRK
|
AU |
|
Easterly Government Properties Inc
NYSE:DEA
|
US |
|
S
|
Shanghai Huitong Energy Co Ltd
SSE:600605
|
CN |
|
goeasy Ltd
TSX:GSY
|
CA |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
US |
|
I
|
Iceland Seafood Internat hf
ICEX:ICESEA
|
IS |
|
T
|
Tijaria Polypipes Ltd
NSE:TIJARIA
|
IN |
|
Borosil Ltd
NSE:BOROLTD
|
IN |
|
S
|
Svenska Cellulosa SCA AB
XBER:SCA
|
SE |
|
Ban Leong Technologies Ltd
SGX:B26
|
SG |
|
B
|
Bank of Montreal
NYSE:BMO
|
CA |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
|
ALK-Abello A/S
F:4AJ0
|
DK |
|
S
|
Snow Lake Resources Ltd
NASDAQ:LITM
|
CA |
Multiples-Based Value
The Multiples-Based Value for MoonLake Immunotherapeutics (MLTX) under the Base Case is hidden USD. Compared with the current market price of 17.36 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MLTX Multiples-Based Value
LOCKED
Multiples Across Competitors
MLTX Competitors Multiples
MoonLake Immunotherapeutics Competitors
MoonLake Immunotherapeutics Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
1.2B USD | 0 | -5.3 | -3.7 | -3.7 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
242.1B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.3B ZAR | 5.6 | 10.4 | 14.2 | 14.2 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
65.9B USD | 0 | 37 214.9 | -17 426.2 | -17 426.2 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.7B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
41.3B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.2B EUR | 1 | 161.8 | 29.2 | 61.2 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
32.1B USD | 13.4 | -2 951.6 | -3 884 | -624 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
28.2B ZAR | 5.3 | 6.5 | 16.9 | 16.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
